Navigation Links
International Oncology Innovators Meeting in Hamburg
Date:11/7/2012

OSLO, Norway, November 7, 2012 /PRNewswire/ --

European Cancer Cluster Partnering (ECCP) 2012

ON SUNDAY, 11 NOVEMBER, representatives from the pharmaceutical industry, leaders in biotechnology and academic centres  will descend on Hamburg, Germany, for a conference seeking to ease the "bench to bedside" transition. The 4th annual European Cancer Cluster Partnering event brings together a diverse and international community looking to develop market-ready innovations in oncology.

This year again, the European Cancer Cluster Partnering (ECCP) event will focus on "Building partnerships to accelerate innovation in oncology" and invites leaders in drug development to attend.

INNOVATION IN ONCOLOGY

To expand its public, ECCP2012 is organised as a satellite event of the European biotech industry autumn gathering BIO-Europe®, held in Hamburg 12 - 14 November.

The opening session will be dedicated to "Driving innovation in oncology: novel partnerships, clinical trials and financial models", and pharma leaders such as Sanofi , but also to world-class academic researchers and investors will address attendees.

The opening session will be followed by a company presentation session dedicated to innovative technology platforms. "Oncology partnering needs" will be addressed by MSD to provide an actualized view about licensing and external research strategies. A selection of "oncology startups to watch" will then be presented together with personalized medicine partnering opportunities.

TOP SPEAKERS ON DRUG DEVELOPMENT

The intensive one day event promises to deliver a forum of effective discussion on the potential opportunities in drug development and showcase the emerging products that can facilitate this growth. With years of experience in the pharmacology and biotech sectors, and with extensive knowledge on business development, Dr Sven Rohmann, Burrill & Company and David T Phillips, Partner SR One (the corporate venture capital arm of GlaxoSmithKline) will deliver a speech on the oncology investment landscape and the role of corporate venture funds.

"ECCP 2012 will be a unique opportunity to gather and to create partnerships between biotech, pharma, investors, clinicians and translational academic centres," the organisers confirm. "Launched three years ago by the French Cancer- Bio-Santé Cluster (located in Toulouse) and the Norwegian based Oslo Cancer Cluster, ECCP will propose an innovative, compact format in 2012, but will keep its unique, convivial and effective spirit."

SATELLITE EVENT TO BIO-EUROPE®

Immediately following ECCP2012, Europe's largest partnering conference, BIO-Europe®, will be held 12-14 November and will complement the dialogue established at this cancer focused event. The ECCP community continues to grow and with more than 20 countries attending in 2011, there is real scope for international penetration at this year's event.

Welcome to ECCP2012, 11 November in Hamburg!

ABOUT ECCP

Since 2009 ECCP - European Cancer Cluster Partnering, has been established as an annual partnering arena for the international oncology community.

ECCP offers a vital networking arena for the international oncology community and is the direct result of the close collaboration between two of Europe's strongest cancer clusters, the French Cancer-Bio Santé Cluster and the Norwegian Oslo Cancer Cluster. The key goal of ECCP is building partnerships to accelerate innovation in cancer treatment.

The 3rd ECCP in 2011 attracted 445 participants from 20 countries. The delegates benefited from 640 prescheduled on-to-one meetings. 1800 formal and informal contacts were reported and almost 40% of the participants estimated two agreements as result from their attendance. 97% of the participants were very satisfied or satisfied with the program and enjoyed excellent networking.

89% stated they were planning to attend ECCP 2012.

FOR INFORMATION contact Jutta Heix, international advisor, Oslo Cancer Cluster, jh@radforsk.no.

For updated program see official website: http://www.ecc-partnering.com


'/>"/>
SOURCE European Cancer Cluster Partnering(ECCP2012)
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
5. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
6. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
7. PAREXEL International to Present at J.P. Morgan Healthcare Conference
8. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform: NursingChina.com
9. Senior Management of NeoStem and Its Subsidiaries Invited to Speak at Seventh International Conference on Cell Therapy for Cardiovascular Disease
10. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
11. BioRestorative Therapies to Present at 7th International Conference on Cell Therapy for Cardiovascular Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... -- Research and Markets has announced the addition of ... their offering. ... The report provides separate comprehensive analytics for the US, ... World. Annual estimates and forecasts are provided for the period 2015 ... markets. Market data and analytics are derived from primary and secondary ...
(Date:2/17/2017)...  If only one in every hundred cells ... to chemotherapy, thousands of cancer cells would remain ... finding these mutations in ever-smaller subpopulations of tumor ... in blood — to guide treatment decisions and ... however, detecting these genetic anomalies may be more ...
(Date:2/16/2017)... ... ... EIT Digital has launched work to develop a new Smart IOT ... to get under way for the framework, which is designed to reduce the use ... to be transferred eventually to other industries that also require efficient IoT and management ...
(Date:2/16/2017)... PARK, Calif. and GREENWICH, ... Capital, a private investment firm focused on venture ... announced the promotion of Josh Richardson , ... focuses on investments in biotechnology companies.  He is ... has played important roles in Longitude,s investments in ...
Breaking Biology Technology:
(Date:2/3/2017)... SAN ANTONIO , Feb. 3, 2017  Texas Biomedical ... Dr. Larry Schlesinger as the Institute,s ... of Texas Biomed effective May 31, 2017. He is currently ... and Director of the Center for Microbial Interface Biology at ... Dr. Schlesinger as the new President and CEO of Texas ...
(Date:2/2/2017)... , Feb. 2, 2017   TapImmune, Inc. ... immuno-oncology company specializing in the development of innovative ... treatment of cancer and metastatic disease, announced today ... GMP manufacturing of a second clinical lot of ... folate receptor alpha. The manufactured vaccine product will ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
Breaking Biology News(10 mins):